Market Challenges Transform Traditional Paths of Innovation
By: Brian Verrier, President, Peripheral Vascular, Covidien
Increasingly rigorous regulatory and reimbursement environments have a significant impact on the innovation cycle for both small and large medical device firms. Over the past decade the time and cost to bring a device to market has increased dramatically as further clinical data requirements and regulations have been put in place. Additionally, as reimbursement continues to move from a fee-for-service to an outcomes-based model, the “innovation paradigm” continues to shift. Read More...